Cyclacel Pharmaceuticals :
CYCCP
CYCCP
Stock Data
$5.05
$0.00 (0.00%)
Asset Type
Preferred Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey.
All Cyclacel Pharmaceuticals Articles
1 Article
No articles found for Cyclacel Pharmaceuticals.